The Gleason score shift: Score four and seven years ago

International Journal of Radiation Oncology Biology Physics

Volumn 56, Issue 5, 2003, Pages 1241-1247

  Chism, Derek B ^a   Hanlon, Alexandra L ^b   Troncoso, Patricia ^b   Al Saleem, Tahseen ^a   Horwitz, Eric M ^a   Pollack, Alan ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Gleason score; Gleason shift; Prostate cancer; Stage migration; Will Rogers effect

Indexed keywords

DISEASE CONTROL; HORMONES; PATHOLOGY; PATIENT TREATMENT; RADIOTHERAPY;

MATCHED-PAIR ANALYSIS;

TUMORS;

ANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER GRADING; CANCER RADIOTHERAPY; COHORT ANALYSIS; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; FOLLOW UP; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOLOGIST; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; SCORING SYSTEM; STATISTICAL ANALYSIS;

EID: 0038503651     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(03)00268-2     Document Type: Article

References (22)

1. Amling C.L., Blute M.L., Lerner S.E., et al. Influence of prostate-specific antigen testing on the spectrum of patients with prostate cancer undergoing radical prostatectomy at a large referral practice. Mayo Clin Proc. 73:1998;401-406.
2. Hankey B.F., Feuer E.J., Clegg L.X., et al. Cancer surveillance series: Interpreting trends in prostate cancer - part I Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates . J Natl Cancer Inst. 91:1999;1017-1024.
3. Jhaveri F.M., Klein E.A., Kupelian P.A., et al. Declining rates of extracapsular extension after radical prostatectomy Evidence for continued stage migration . J Clin Oncol. 17:1999;3167-3172.
4. Gilliland F.D., Gleason D.F., Hunt W.C., et al. Trends in Gleason score for prostate cancer diagnosed between 1983 and 1993. J Urol. 165:2001;846-850.
5. Han M., Partin A.W., Piantadosi S., et al. Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer. J Urol. 166:2001;416-419.
6. D'Amico A.V., Chen M., Oh-Ung J., et al. Changing prostate-specific antigen outcome after surgery or radiotherapy for localized prostate cancer during the prostate-specific antigen era. Int J Radiat Oncol Biol Phys. 54:2002;436-441.
7. Stephenson R., Stanford J. Population based prostate cancer trends in the United States Patterns of change in the era of prostate-specific antigen . World J Urol. 15:1997;331-335.
8. Smart C.R. The results of prostate carcinoma screening in the U.S. as reflected in the surveillance, epidemiology, and end results program. Cancer. 80:1997;1835-1844.
9. Smith E.B., Frierson H.F., Mills S.E., et al. Gleason scores of prostate biopsy and radical prostatectomy specimens over the past 10 years. Cancer. 94:2002;2282-2287.
10. Allsbrook W.C., Mangold K.A., Johnson M.H., et al. Interobserver reproducibility of Gleason grading of prostatic carcinoma Urologic pathologists . Hum Pathol. 32:2001;74-80.
11. Allsbrook W.C., Mangold K.A., Johnson M.H., et al. Interobserver reproducibility of Gleason grading of prostatic carcinoma General pathologist . Hum Pathol. 32:2001;81-88.
12. Schellhammer P., Moriarty R., Bostwick D., et al. Fifteen-year minimum follow-up of a prostate brachytherapy series Comparing the past with the present . Urology. 56:2000;436-439.
13. Manual for staging of cancer. 4 ed:1997;JB Lippincott, Philadelphia.
14. Fleiss JL. Statistical methods for rates and proportions. 2nd edition. 1981.
15. Vicini F., Kestin L., Martinez A. The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancer. Int J Radiat Oncol Biol Phys. 45:1999;553-561.
16. Horwitz E, Uzzo R, Hanlon A, et al. Does back dating change outcome when the ASTRO definition of biochemical control is used in patients with clinically localized prostate cancer treated with 3D conformal radiotherapy alone? Int J Radiat Oncol Biol Phys 2002;Suppl 54:Abstract 14.
17. Consensus statement: Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys. 37:1997;1035-1041.
18. Cowen D., Troncoso P., Khoo V.A., et al. Ki-67 staining is an independent correlate of biochemical failure in prostate cancer treated with radiotherapy. Clin Cancer Res. 8:2002;1148-1154.
19. Wilcoxon F. Individual comparison by ranking methods. Biometrics. 1:1945;80-83.
20. Feinstein A.R., Sosin D.M., Wells C.K. The Will Rogers phenomenon Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer . N Engl J Med. 312:1985;1604-1608.
21. Pan C., Potter S.R., Partin A.W., et al. The prognostic significance of tertiary Gleason patterns of higher grade in radical prostatectomy specimens. Am J Surg Pathol. 24:2000;563-569.
22. Epstein J.I. Gleason score 2-4 Adenocarcinoma of the prostate on needle biopsy. Am J Surg Pathol. 24:2000;477-478.